Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

We have observed 64 EP applications Robert Andrews has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 16, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12702627

PERSONALIZED PRODUCTION OF BIOLOGICS AND METHOD FOR REPROGRAMMING SOMATIC CELLS

IPC classification:
C12N 5/10
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13190752

Monomethylvaline compounds having phenylalanine side-chain modifications at the C-terminus

IPC classification:
A61K 38/00, A61K 47/48, C07K 7/02
Applicant:
Seattle Genetics, Inc.
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12858799

VEHICLE SEAT BACK

IPC classification:
A47C 7/40, B60N 2/64
Applicant:
JSP CORPORATION
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12861250

IMMUNOGLOBULIN FC VARIANTS

IPC classification:
A61K 39/395, C07K 16/28, C07K 19/00
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14166640

Method for treating neurological disorders with imidazolium and imidazolinium compounds

IPC classification:
A61K 31/4164, A61K 31/4184, A61K 31/4196, A61P 25/16, A61P 25/18, C07D 233/06, C07D 233/58, C07D 233/60, C07D 233/61, C07D 235/20, C07D 249/16, C07D 401/04, C07D 401/14
Applicant:
Agency for Science, Technology and Research
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13757904

AN IMPROVED PROCESS FOR PREPARATION OF PHYSIOLOGICALLY ACTIVE POLYPEPTIDE COMPLEX

IPC classification:
A61K 47/48, C07K 1/10, C07K 19/00
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13760453

METHOD OF CULTURING E. COLI CELLS FOR HIGH DENSITY

IPC classification:
C12N 1/21, C12N 15/70, C12Q 1/02
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13718040

STEM CELLS FROM THE MAMMALIAN NEURAL PLATE

IPC classification:
C12N 5/0797
Applicant:
Cambridge Enterprise Ltd.
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13807294

STRUCTURAL BODY FOR SHAFT, MALE MEMBER, AND FEMALE MEMBER

IPC classification:
F16D 1/02, F16D 3/06
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13806918

BALL SCREW, SEAL MATERIAL, AND SEAL STRUCTURE

IPC classification:
F16H 25/22, F16H 25/24, F16J 15/18
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13812943

NOVEL PEPTIDES AND USE THEREOF

IPC classification:
A61K 38/10, A61P 29/00, C07K 7/06, C07K 7/08
Applicant:
Samsung Life Public Welfare Foundation
Applicant:
Industry-Academic Cooperation Foundation, Sookmyun Women's University
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13822348

A LIQUID FORMULATION OF LONG-ACTING INSULIN CONJUGATE

IPC classification:
A61K 9/08, A61K 38/26, A61K 38/28, A61K 47/48
Applicant:
Hanmi Pharm. Co., Ltd.
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13822545

A LIQUID FORMULATION OF LONG-ACTING INSULIN AND INSULINOTROPIC PEPTIDE

IPC classification:
A61K 9/08, A61K 38/18, A61K 38/28
Applicant:
Hanmi Pharm. Co., Ltd.
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13793632

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING STAT3-MEDIATED DISEASE, COMPRISING SALVIA PLEBEIA R. BR. EXTRACT OR FRACTION THEREOF AS ACTIVE INGREDIENTCOMPOSITION PHARMACEUTIQUE POUR LA PRÉVENTION OU LE TRAITEMENT DE MALADIES MÉDIÉES PAR STAT-3, CONTENANT UN EXTRAIT OU UNE FRACTION DE SALVIA PLEBEIA R. BR. EN TANT QUE PRINCIPE ACTIF

IPC classification:
A61K 36/31, A61P 29/00
Applicant:
Korea Research Institute of Bioscience and Biotechnology (KRIBB)
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
The patent has been granted
EP13836998

SYNTHETICALLY DESIGNED EXTRACELLULAR MICROENVIRONMENT

IPC classification:
A61K 38/17, A61K 38/18, A61K 47/48, A61K 48/00
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13858153

A STABILIZED PEMETREXED FORMULATION

IPC classification:
A61K 31/517, A61K 31/519, A61P 35/00
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP15164488

GENES ENCODING BIOFILM FORMATION INHIBITORY PROTEINS AND A METHOD FOR PRODUCING L-LYSINE USING A BACTERIAL STRAIN WITH THE INACTIVATED GENES

IPC classification:
C07K 14/34, C12N 15/52, C12N 15/63
Applicant:
Cj Cheiljedang Corporation
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14735289

INSULIN SECRETION PEPTIDE DERIVATIVE IN WHICH CHARGE ON N-TERMINUS IS MODIFIED

IPC classification:
A61P 3/10, C07K 14/575
Applicant:
Hanmi Pharm. Co., Ltd.
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP15166938

IMPROVED PROCESS FOR PREPARING FERMENTED SOYBEAN MEAL

IPC classification:
A23L 1/20
Applicant:
Cj Cheiljedang Corporation
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14742746

THERAPEUTIC COMPOUNDS

IPC classification:
A61K 8/97, A61K 36/9068, C08G 8/32
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14746164

RECOMBINANT YEAST TRANSFORMANT AND PROCESS FOR PREPARING IMMUNOGLOBULIN FC FRAGMENT EMPLOYING THE SAME

IPC classification:
C12N 1/19, C12N 15/13, C12N 15/81
Applicant:
Hanmi Pharm. Co., Ltd.
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14746007

A METHOD OF VIRUS INACTIVATION IN COMPOSITION COMPRISING FACTOR VII

IPC classification:
A61K 38/36, A61P 31/12
Applicant:
Hanmi Pharm. Co., Ltd.
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13862129

SKIN-MOISTURISING OR WRINKLE-IMPROVING EXTERNAL COMPOSITION AND COSMETIC COMPOSITION

IPC classification:
A61K 31/40, A61K 31/56, A61K 31/70, A61K 31/7028
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14757629

NOVEL INSULIN ANALOG AND USE THEREOF

IPC classification:
A61K 47/48, C07K 14/62
Applicant:
Hanmi Pharm. Co., Ltd.
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15764693

TEMPORARY RESIN-BASED CROWN

IPC classification:
A61C 5/08, A61C 13/087, A61L 27/14
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14757574

SITE-SPECIFIC INSULIN CONJUGATE

IPC classification:
A61K 38/28, A61P 3/10, C07K 14/62, C07K 17/08
Applicant:
Hanmi Pharm. Co., Ltd.
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14760968

IMPROVED PREPARATION METHOD FOR HIGH-YIELD PRODUCTION OF PHYSIOLOGICALLY ACTIVE POLYPEPTIDE CONJUGATE

IPC classification:
C07K 14/62, C07K 16/00, C07K 19/00
Applicant:
Hanmi Pharm. Co., Ltd.
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14768563

RECOMBINANT MICROORGANISM FOR PUTRESCINE PRODUCTION AND METHOD FOR PRODUCING PUTRESCINE USING SAME

IPC classification:
C12N 1/21, C12N 15/52
Applicant:
Cj Cheiljedang Corporation
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13881695

POSTURE CORRECTION DEVICE

IPC classification:
A61F 5/01
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14795085

STABILIZED PEMETREXED PREPARATION

IPC classification:
A61K 9/08, A61K 31/517, A61K 31/519
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14794775

NOVEL RHTB PROTEIN VARIANTS AND THE METHOD OF PRODUCING O-PHOSPHOSERINE USING THE SAME

IPC classification:
C07K 14/195, C12N 15/31, C12N 15/63, C12P 13/06
Applicant:
Cj Cheiljedang Corporation
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14795225

NOVEL O-PHOSPHOSERINE EXPORT PROTEIN AND THE METHOD OF PRODUCING O-PHOSPHOSERINE USING THE SAME

IPC classification:
C07K 14/195, C12N 1/21, C12N 15/31, C12P 13/06
Applicant:
Cj Cheiljedang Corporation
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14728259

FISH VACCINE

IPC classification:
A61K 38/16, C07K 14/37, C12N 15/62
Applicant:
University Court Of The University Of Aberdeen - Research and Innovation
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14804503

IGG4 FC FRAGMENT COMPRISING MODIFIED HINGE REGION

IPC classification:
A61K 47/42, C07K 7/08, C12N 15/13, C12N 15/63
Applicant:
Hanmi Pharm. Co., Ltd.
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14822721

IMMUNOGLOBULIN FC CONJUGATE MAINTAINING FCRN BINDING STRENGTH

IPC classification:
C07K 16/46, C07K 19/00
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14823791

BIOACTIVE POLYPEPTIDE MONOMER-IMMUNOGLOBULIN FC FRAGMENT CONJUGATE HAVING DECREASED RECEPTOR-MEDIATED CLEARANCE, AND METHOD FOR PREPARING SAME

IPC classification:
A61K 38/26, A61K 39/395, A61K 47/48
Applicant:
Hanmi Pharm. Co., Ltd.
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14839952

METHOD FOR MASS PRODUCING HUMAN BLOOD COAGULATION FACTOR VII DERIVATIVE

IPC classification:
C12N 15/12, C12N 15/85, C12P 21/02
Applicant:
Hanmi Pharm. Co., Ltd.
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14847086

SUSTAINED TYPE HUMAN GROWTH HORMONE PREPARATION

IPC classification:
A61K 9/19, A61K 38/25, A61K 38/27, A61K 47/30
Applicant:
Hanmi Pharm. Co., Ltd.
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP16164639

CONSTRUCTION OF HIGHLY EFFICIENT CELLULASE COMPOSITIONS FOR ENZYMATIC HYDROLYSIS OF CELLULOSE

IPC classification:
C12N 9/14, C12P 19/04
Applicant:
Danisco US Inc.
Agent:
Robert Andrews, Mewburn Ellis LLP
Agent:
Nederlandsch Octrooibureau N.V.
Status:
EXAMINATION REQUESTED
EP15737856

LONG-ACTING INSULIN AND USE THEREOF

IPC classification:
A61K 38/28, A61P 3/10, C07K 14/62
Applicant:
Hanmi Pharm. Co., Ltd.
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15743540

BACILLUS SP. STRAIN HAVING IMPROVED FERMENTED SOYBEAN MEAL PRODUCTIVITY, AND METHOD FOR PREPARING FERMENTED SOYBEAN MEAL BY USING SAME

IPC classification:
C12N 1/20, C12P 1/04, C12R 1/07
Applicant:
Cj Cheiljedang Corporation
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15772562

METHOD FOR IMPROVING SOLUBILITY OF PROTEIN AND PEPTIDE BY USING IMMUNOGLOBULIN FC FRAGMENT LINKAGE

IPC classification:
C07K 1/02, C07K 19/00
Applicant:
Hanmi Pharm. Co., Ltd.
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15776058

MICROORGANISM HAVING L-LYSINE PRODUCING ABILITY AND L-LYSINE PRODUCING METHOD USING SAME

IPC classification:
C12N 1/20, C12N 1/21, C12P 13/08, C12R 1/15
Applicant:
Cj Cheiljedang Corporation
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15779202

PHARMACEUTICAL COMPOSITION COMPRISING PISTACIA WEINMANNIFOLIA EXTRACT, FRACTION OF SAME OR COMPOUND SEPARATED FROM SAME FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

IPC classification:
A61K 36/22, A61P 11/00
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15799077

COMPOSITION FOR TREATING DIABETES MELLITUS COMPRISING INSULIN AND A GLP-1/GLUCAGON DUAL AGONIST

IPC classification:
A61K 38/26, A61K 38/28, A61P 3/00, A61P 3/10
Applicant:
Hanmi Pharm. Co., Ltd.
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15800090

METHOD FOR SENSITIVE DETECTION OF TARGET DNA USING TARGET-SPECIFIC NUCLEASE

IPC classification:
C12Q 1/68, G01N 33/53, G01N 33/574
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15803380

FEED ADDITIVE COMPOSITION FOR REDUCING METHANE PRODUCTION OF RUMINANTS

IPC classification:
A23K 10/40
Applicant:
Cj Cheiljedang Corporation
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15802343

METHOD FOR DECREASING IMMUNOGENICITY OF PROTEIN AND PEPTIDE

IPC classification:
A61K 39/395, A61P 37/06, C07K 16/46
Applicant:
Hanmi Pharm. Co., Ltd.
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15799334

COMPOSITION FOR TREATING DIABETES, CONTAINING LONG-ACTING INSULIN ANALOG CONJUGATE AND LONG-ACTING INSULIN SECRETION PEPTIDE CONJUGATE

IPC classification:
A61K 38/26, A61K 38/28, A61K 47/30, A61K 47/50
Applicant:
Hanmi Pharm. Co., Ltd.
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15756443

ADSORBENT PARTICLE PROCESS MANAGEMENT

IPC classification:
B01J 20/30, B01J 20/32, B01J 20/34
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15830563

6-ARYL AMINO PYRIDONE FORMAMIDE COMPOUND CRYSTAL AND PREPARATION METHOD THEREFOR

IPC classification:
A61K 31/4355, A61P 29/00, A61P 35/00, C07D 491/048
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15832358

O-PHOSPHOSERINE PRODUCING MICROORGANISM AND METHOD FOR PRODUCING O-PHOSPHOSERINE OR L-CYSTEINE USING SAME

IPC classification:
C12N 1/21, C12P 13/06, C12P 13/12
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15836879

NON-METALLIC ANTI-EXPLOSION BALL

IPC classification:
A62C 3/06, B60K 15/077, C08L 77/06, F17C 13/12
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15837358

MICROORGANISM WITH IMPROVED L-LYSINE PRODUCTIVITY, AND METHOD FOR PRODUCING L-LYSINE BY USING SAME

IPC classification:
C12N 9/12, C12N 15/54, C12P 13/08, C12R 1/15
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
Request for examination was made
EP15794199

SLFN11 AS BIOMARKER FOR AML

IPC classification:
G01N 33/574
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
Request for examination was made
EP15852781

USE OF AZELNIDIPINE IN PREPARING MEDICINAL COMPOSITION FOR TREATING CANCERS

IPC classification:
A61K 31/4422, A61P 35/00, A61P 35/04
Agent:
Robert Andrews, Mewburn Ellis LLP
Agent:
Florian Schwerbrock, Lee & Schwerbrock GbR
Status:
Request for examination was made
EP15801398

PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES

IPC classification:
A61P 35/00, A61K 47/50
Applicant:
MedImmune Limited
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
Request for examination was made
EP15851742

USES OF CINACALCET HCL IN PREPARING PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CANCER

IPC classification:
A61K 31/137, A61P 35/00
Agent:
Robert Andrews, Mewburn Ellis LLP
Agent:
Florian Schwerbrock, Lee & Schwerbrock GbR
Status:
Request for examination was made
EP15787270

PARTICLE ENTRAINED AIR-PERMEABLE STRUCTURES

IPC classification:
A61F 13/15, A61F 13/533
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
Request for examination was made
EP15875680

GLUCAGON DERIVATIVE HAVING IMPROVED STABILITY

IPC classification:
A61K 38/26, A61P 3/04, C07K 14/605
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
Request for examination was made
EP17179428

BETA-GLUCURONIDE DRUG LINKER CONJUGATES

IPC classification:
A61K 39/00, C07K 16/00
Applicant:
Seattle Genetics, Inc.
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
The application has been published
EP16706895

METHODS FOR THE INHIBITION AND DISPERSAL OF BIOFILMS USING AURANOFIN

IPC classification:
A01N 43/16, A01N 43/60, A01N 59/16, A01P 1/00
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
Request for examination was made
EP16756426

STIMULATION OF APPETITE, MANAGEMENT OF WEIGHT LOSS, AND TREATMENT OF ANOREXIA IN DOGS AND CATS

IPC classification:
A61K 9/70, A61K 31/55
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
Request for examination was made
EP16759415

COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF PYREXIA IN HORSES

IPC classification:
A61K 31/66, A61P 25/04
Agent:
Robert Andrews, Mewburn Ellis LLP
Status:
Request for examination was made

Please Sign in to use this feature